Regeneron Pharmaceuticals is a biopharmaceutical company that discovers, develops, and commercializes pharmaceutical products for the treatment of serious medical conditions. The Company has therapeutic candidates in clinical trials for the potential treatment of cancer, eye diseases, and inflammatory diseases, and has preclinical programs in other diseases and disorders. The company’s product portfolio includes EYLEA, an aflibercept injection; ARCALYST, a rilonacept Injection for subcutaneous use; ZALTRAP for metastatic colorectal cancer; trap fusion proteins; and fully human monoclonal antibodies. On March 26, 2012, it was announced that Sanofi and Regeneron are in development with a new cholesterol drug which will help reduce cholesterol up to 72%. Regeneron Pharmaceuticals was founded in 1988 and is currently headquartered in New York, USA.

Celavie Biosciences is changing the paradigm of stem cell technology to improve lives and restore hope. In addition to treating Parkinson's and other conditions affecting the nervous system, they develop regenerative stem cell treatments. Their medical needs are significant, as these conditions result in loss of basic functions or mortality.

MedImmune develops medicines for unmet medical needs worldwide. As the global biologics research and development arm of AstraZeneca, MedImmune is pioneering innovative research and exploring novel pathways across key therapeutic including respiratory, inflammation, and autoimmunity; cardiovascular and metabolic disease; oncology; neuroscience; and infection and vaccines. Since its founding in 1988, MedImmune has remained committed to scientific innovation and medical progress, continually looking beyond standard expectations and pushing the boundaries of what is possible.

Part of The Wonderful Co. LLC, POM Wonderful LLC is a company headquartered in Los Angeles, CA. The firm wholesales cherry, blueberry juices and tea products.\nThe company says this about itself: POM Wonderful is the largest grower and producer of fresh pomegranates and pomegranate juice in the United States as well as the worldwide leader in fresh California pomegranates and pomegranate-based products including our 100% pomegranate juices, healthy juice blends, and teas. We grow, handpick, and juice our own pomegranates to ensure the highest quality. POM Wonderful is part of The Wonderful Company, a privately held company with a portfolio that includes other No. 1 brands such as Wonderful® Pistachios, FIJI® Water, Wonderful® Halos®, JUSTIN® wine, and Teleflora®.

Asahi Kasei Medical Co. Ltd. engages in the development, manufacture and sale of medical devices. It also engages in the development, manufacture and sale of dialyzers, therapeutic apheresis products, leukocyte reduction filters and virus removal filters. The company was founded on July 24, 1974 and is headquartered in Tokyo, Japan.

At Phadia, they develop, manufacture and market complete blood test systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases. For more than 40 years, they have been focused on delivering results, and they are proud to report that, in that time, they have maintained leadership in allergy testing and become one of the world's leading autoimmune disease test providers. Headquartered in Uppsala, Sweden, their international centre of excellence is at the heart of it all. The site of their strategic management, administration and business development activities, it’s also the home of extensive research and development as well as world-class manufacturing facilities. They also have a site in Southern Sweden, where development of their allergen raw materials takes place. In Freiburg, Germany, a third centre of excellence develops, manufactures and supports diagnostic tests for autoimmune diseases. Recently, a fourth centre of excellence was established in Vienna, Austria, to handle the development and production of assay systems, based on multiplex technology, for both allergy and autoimmunity. Together, these four centres enable us to remain focused on excellence as they respond to the diagnostic needs of the world.

Kling Biotherapeutics BV is a company headquartered in Amsterdam, the Netherlands. The firm develops novel antibody based therapeutics. Michael Koslowski is currently the CEO of the company.\nThe company says this about itself: Kling Biotherapeutics is an Amsterdam, NL based clinical-stage biotechnology company that has developed a robust pipeline based on evaluating B cells present in individuals with remarkable responses to cancer and infectious diseases. Its proprietary B cell immortalization platform enables rapid functional screening of antibodies and has led to the identification of several antibodies targeting novel epitopes (cancer and infectious diseases) and cancer associated antigens with unique post-translational modifications.

MEDINET Co., Ltd. engages in cell processing business. It offers solutions for regenerative medicine and cell therapy. It operates through the Cell Processing and Regenerative Medical Products segments. The Cell Processing segment includes manufacturing of specific cell-processed products for medical institutions; contracts for clinical and trial cell processing from companies, universities, research institutions; and contracts for operation of cell culture processing facilities. The Regenerative Medical Products segment deals with research and development for the acquisition of manufacturing and marketing approval for regenerative medicine products. The company was founded by Yoshiji Kimura and Kohji Egawa on October 17, 1995 and is headquartered in Tokyo, Japan.

Develops pharmaceutical products

AIMM Therapeutics BV develops therapeutic antibodies for the treatment of cancer and infectious diseases. Its antibody discovery platform couples proprietary knowledge of B cell immortalization with the isolation of antibodies from humans or animals. The company was founded by Donald Kalff and Hergen Spits in 2004 and is headquartered in Amsterdam, the Netherlands.

Forschungszentrum Jülich ("Jülich Research Centre") is a member of the Helmholtz Association of German Research Centres and is one of the largest interdisciplinary research centres in Europe. It was founded on 11 December 1956 by the state of North Rhine-Westphalia as a registered association, before it became "Kernforschungsanlage Jülich GmbH" or Nuclear Research Centre Jülich in 1967. In 1990, the name of the association was changed to "Forschungszentrum Jülich GmbH". It has close collaborations with RWTH Aachen in the form of Jülich-Aachen Research Alliance (JARA).

Flamel Technologies SA engages in the research, development and commercialization of pharmaceutical products. Its portfolio includes Bloxiverz, Vazculep, Micropump, LiquiTime, Trigger Lock and Medusa. The company was founded by Gérard Soula in August 1990 and is headquartered in Vénissieux, France.

Automation Research & Design Institute of Metallurgical (doing business as Metallurgical Industry Automation Research & Design Institute) is a Chinese company located in Beijing and ultimately controlled by the Government of China involved in air-cond./warm air htg. equip. and comm./ind. refrig. equip.. Jian Wu Zhang has been the CEO since 2007.

Cetus Corporation was one of the first biotechnology companies. It was established in Berkeley, California in 1971, but conducted most of its operations in nearby Emeryville. Before merging with another company in 1991, it developed several significant pharmaceutical drugs as well as a revolutionary DNA amplification technique.